Metabolic Diet for Relapse Prevention in Anorexia Nervosa

Status: Recruiting
Location: See location...
Intervention Type: Dietary supplement
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This is an interventional study that will test the safety, tolerability, and efficacy of the Metabolic Diet, which was designed as a treatment for women with anorexia nervosa to remain weight-stable after they have been restored from low weight. Participants will be adult women with anorexia nervosa who have been recently restored to normal weight and adult women with no history of eating disorders. After enrollment, participants will start meeting weekly with a registered dietitian to implement the Metabolic Diet in their daily lives, and will receive medical monitoring for adherence, side effects, changes in metabolic or psychological parameters, and weight stability.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Maximum Age: 40
Healthy Volunteers: t
View:

• Female

• Age at least 18 and not over 40

• BMI at or above 18.5 kg/m2

• Speaks English

• Medically stable, as cleared by a licensed physician, with vital signs and initial blood draws

• History of DSM-5 diagnosis of Anorexia Nervosa (WR-AN only)

• Weight-restored from underweight BMI (under 18.5 kg/m2) within the past 6 months (WR-AN only)

Locations
United States
New York
Icahn School of Medicine at Mount Sinai
RECRUITING
New York
Contact Information
Primary
Chinara Tate
chinara.tate@mssm.edu
(212) 659-8724
Backup
Tom Hildebrandt
tom.hildebrandt@mssm.edu
212-659-8673
Time Frame
Start Date: 2022-11-20
Estimated Completion Date: 2026-12
Participants
Target number of participants: 20
Treatments
Active_comparator: Women with anorexia nervosa
adult women with anorexia nervosa who have been recently restored to normal weight
Active_comparator: Women with no history of eating disorders
adult women with no history of eating disorders
Authors
Tom Hildebrandt
Related Therapeutic Areas
Sponsors
Leads: Icahn School of Medicine at Mount Sinai

This content was sourced from clinicaltrials.gov